HEBEL, T., B. LANGGUTH, M. SCHECKLMANN, S. SCHOISSWOHL, S. STAUDINGER, A. SCHILLER,
Libor USTOHAL,
Tomáš SVĚRÁK,
Martin HORKÝ,
Tomáš KAŠPÁREK, T. SKRONT, M. HYZA, T. B. POEPPL, M L RIESTER, L. SCHWEMMER, S. ZIMMERMANN a K. SAKREIDA. Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN).
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. SAN DIEGO: ELSEVIER INC, 2022, roč. 26, April 2022, s. 1-5. ISSN 2451-8654. Dostupné z: https://dx.doi.org/10.1016/j.conctc.2022.100891.